Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Inventory (2017 - 2025)

Historic Inventory for RedHill Biopharma (RDHL) over the last 9 years, with Q2 2025 value amounting to $3.2 million.

  • RedHill Biopharma's Inventory fell 1669.3% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.2 million, marking a year-over-year decrease of 1669.3%. This contributed to the annual value of $3.7 million for FY2024, which is 1681.48% down from last year.
  • RedHill Biopharma's Inventory amounted to $3.2 million in Q2 2025, which was down 1669.3% from $3.7 million recorded in Q4 2024.
  • Over the past 5 years, RedHill Biopharma's Inventory peaked at $14.3 million during Q1 2022, and registered a low of $3.2 million during Q2 2025.
  • Its 5-year average for Inventory is $8.2 million, with a median of $8.2 million in 2021.
  • Its Inventory has fluctuated over the past 5 years, first surged by 23501.99% in 2021, then crashed by 6013.26% in 2023.
  • RedHill Biopharma's Inventory (Quarter) stood at $7.7 million in 2021, then surged by 42.97% to $11.0 million in 2022, then tumbled by 60.13% to $4.4 million in 2023, then fell by 16.81% to $3.7 million in 2024, then dropped by 13.2% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q2 2025, $3.7 million for Q4 2024, and $3.8 million during Q2 2024.